PROPOSED ADMISSION TO TRADING ON AIM AND SUCCESSFUL CONDITIONAL CAPITAL RAISE OF €9.7 MILLION

Novacyt proposed admission to AIM ENG Paris, France and Cambridge, UK – 18th October 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces that it has raised a total of €9.7 million (before expenses) through a conditional placing (the “Placing”) of 7,051,590 new shares (the “Placing Shares”), raising €4.7 million, and

Visit Page